This Article  • Full text  • PDF  • Correction  • Original article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Treatment Adherence  • Cardiovascular System  • Cardiovascular Disease/ Myocardial Infarction  • Adverse Effects  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Tricoci et al¹ examined over 60 000 patients with high-risk non–ST-segment elevation acute coronary syndrome (NSTE ACS) in the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA [American College of Cardiology/American Heart Association] Guidelines) Quality Improvement Initiative. They found that only slightly over half received clopidogrel at discharge and the majority who did not undergo catheterization did not receive clopidogrel. The patterns and trends for receiving clopidogrel were similar for patients who received care by cardiologists or noncardiologists, a fact that might seem surprising in light of published guidelines.²

Perhaps this is not as surprising as it first appears. Guideline recommendations regarding dual antiplatelet therapy for patients with NSTE ACS were driven largely by the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) trial,³ in which the primary outcome measure of cardiovascular death, nonfatal myocardial infarction, and stroke was significantly . . . [Full Text of this Article]

AUTHOR INFORMATION
Roy C. Ziegelstein, MD

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Clopidogrel to Treat Patients With Non–ST-Segment Elevation Acute Coronary Syndromes After Hospital Discharge
Pierluigi Tricoci, Matthew T. Roe, Jyotsna Mulgund, L. Kristin Newby, Sidney C. Smith, Jr, Charles V. Pollack, Jr, Dan J. Fintel, Christopher P. Cannon, Deepak L. Bhatt, W. Brian Gibler, E. Magnus Ohman, Eric D. Peterson, and Robert A. Harrington
Arch Intern Med. 2006;166(7):806-811.
ABSTRACT | FULL TEXT